Covid-19: Remdesivir has little or no impact on survival, WHO trial shows
BMJ
.
2020 Oct 19:371:m4057.
doi: 10.1136/bmj.m4057.
Author
Owen Dyer
1
Affiliation
1
Montreal.
PMID:
33077424
DOI:
10.1136/bmj.m4057
No abstract available